Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06485336 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prophylactic Treatment With Atorvastatin for Chronic Migraine (ChronicStatinMig)

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. 2 versions Re-verified since Jun 29, 2025, no change to tracked fieldsv2-v3
  2. Study First Submitted
St. Olavs Hospital
58 trials monitored
See 3 trials at risk
Migraine
482 trials monitored
See 26 trials at risk
The main objective of this study is to see whether the favorable preventative effect of Atorvastatin 40mg per day in episodic migraine, that was found previously in three smaller randomized controlled cross-over studies, can be confirmed in a larger, multicenter, randomized controlled parallel group study. In addition it will be investigated whether 1) the favorable side effect profile, seen in previous studies, can be confirmed, and whether it is even better with the smaller dose, and 2) estimating the cost of Atorvastatin treatment, considering cost of medicine, cost of acute attack medicine, and cost of lost worktime.
Trial Details
NCT Number NCT06485336
Lead Sponsor St. Olavs Hospital
Collaborators: Haukeland University Hospital, Oslo University Hospital, University Hospital of North Norway, University Hospital, Akershus, Ullevaal University Hospital
Conditions
(from sponsor)		 Chronic Migraine
Related terms Migraine Disorders
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov